← brief for 2026-09-22 · Slowing decline

Antiproteinuric Response to Finerenone in Diabetic Kidney Disease: Responder and Non-Responder Subgroup Analysis of the FINDKDLATAM Study

Article C Peer reviewed Observational

Key takeaways

This analysis looked at how people with diabetic kidney disease reacted to a drug called finerenone. It checked if the drug reduced protein in the urine. This shows a link, not proof of cause.

Who did this work

Jorge E. Rico-Fontalvo (American Society of Nephrology) · María Raad Sarabia (Universidad Simón Bolívar) · Jose Carlos de la Flor (Universidad de Alcalá) · Vicente Sánchez Polo (Universidad de San Carlos de Guatemala) · Jennifer Benavides (Universidad del Rosario) · Enrique Ramos Clason (University of Cartagena) · Daniel Domínguez (American Society of Nephrology) · Giovanny Mera Rebutti (University of Guayaquil) · Carlos Madrid Mancia (Honduras Foundation for Agricultural Research) · Rene Tabora López (Honduras Foundation for Agricultural Research) · Manuel Rocha Meza (American Society of Nephrology) · Dany Tabora López (Honduras Foundation for Agricultural Research)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-22
https://doi.org/10.3390/clinpract16100174